GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ACADIA Pharmaceuticals Inc (FRA:DR6) » Definitions » Market Cap

ACADIA Pharmaceuticals (FRA:DR6) Market Cap : €2,574.7 Mil (As of May. 01, 2024)


View and export this data going back to 2004. Start your Free Trial

What is ACADIA Pharmaceuticals Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). ACADIA Pharmaceuticals's share price for the quarter that ended in Dec. 2023 was €28. ACADIA Pharmaceuticals's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 164.7 Mil. Therefore, ACADIA Pharmaceuticals's market cap for the quarter that ended in Dec. 2023 was €4,610.2 Mil.

ACADIA Pharmaceuticals's quarterly market cap declined from Jun. 2023 (€3,561.2 Mil) to Sep. 2023 (€3,312.2 Mil) but then increased from Sep. 2023 (€3,312.2 Mil) to Dec. 2023 (€4,610.2 Mil).

ACADIA Pharmaceuticals's annual market cap declined from Dec. 2021 (€3,382.9 Mil) to Dec. 2022 (€2,403.4 Mil) but then increased from Dec. 2022 (€2,403.4 Mil) to Dec. 2023 (€4,610.2 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. ACADIA Pharmaceuticals's Enterprise Value for Today is €2,218.5 Mil.


ACADIA Pharmaceuticals Market Cap Historical Data

The historical data trend for ACADIA Pharmaceuticals's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ACADIA Pharmaceuticals Market Cap Chart

ACADIA Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,027.78 6,913.92 3,382.88 2,403.42 4,610.20

ACADIA Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,403.42 2,768.97 3,561.16 3,312.17 4,610.20

Competitive Comparison of ACADIA Pharmaceuticals's Market Cap

For the Biotechnology subindustry, ACADIA Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ACADIA Pharmaceuticals's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ACADIA Pharmaceuticals's Market Cap distribution charts can be found below:

* The bar in red indicates where ACADIA Pharmaceuticals's Market Cap falls into.



ACADIA Pharmaceuticals Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

ACADIA Pharmaceuticals's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=€28*164.65
=€4,610.2

ACADIA Pharmaceuticals's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=€28*164.65
=€4,610.2

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ACADIA Pharmaceuticals  (FRA:DR6) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


ACADIA Pharmaceuticals Market Cap Related Terms

Thank you for viewing the detailed overview of ACADIA Pharmaceuticals's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


ACADIA Pharmaceuticals (FRA:DR6) Business Description

Traded in Other Exchanges
Address
12830 El Camino Real, Suite 400, San Diego, CA, USA, 92130
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

ACADIA Pharmaceuticals (FRA:DR6) Headlines

No Headlines